Clinical Trials Directory

Trials / Completed

CompletedNCT03685396

Patient Morbidity After Palatal Free Gingival Grafts With or Without PRF Membranes Coverage

Patient Morbidity After Palatal Free Gingival Grafts With or Without PRF Membranes Coverage: a Comparative Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Azienda Ospedaliera San Paolo · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study evaluates postoperative morbidity of patients that undergo free gingival graft harvesting from palate with or without use of autogenous PRF (Platelet Rich Fibrin) membranes to cover the donor site.In the Test Group venous blood sampling was done in order to prepare PRF membranes used to cover the donor site, whereas in Control Group hemostatic agents with oxidized and regenerated cellulosa were used.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet rich fibrin ( PRF)Venous blood was collected with a butterfly needle in two 10 mL tubes without anticoagulants or other chemicals. The tubes were immediately centrifuged at 3000 rpm for 10 minutes. At the end of centrifugation a fibrin clot (PRF) was obtained in the middle of the tube, just between the red corpuscles at the bottom and acellular plasma at the top. The PRF clot was taken from the tube and the red cells portion at the base of the clot was eliminated with sterile scissors Then the PRF was enveloped in sterile gauzes and positioned between two glass plates: the compression drove out the serum from the clot obtaining PRF membranes that were ready to be used in the surgical site.
DRUGhemostatic agents with oxidized and regenerated cellulosaIn the Control Group hemostatic agents with oxidized and regenerated cellulosa were sutured to the palatal wound with mattress suture ( silk 5/0).

Timeline

Start date
2017-11-27
Primary completion
2018-07-23
Completion
2018-09-09
First posted
2018-09-26
Last updated
2019-08-05
Results posted
2019-08-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03685396. Inclusion in this directory is not an endorsement.